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RESEARCH ARTICLE
Variations in T cell transcription factor 
gene structure and expression associated 
with the two disease forms of sheep 
paratuberculosis
Louise Nicol1, Hazel Wilkie1, Anton Gossner1, Craig Watkins2, Robert Dalziel1 and John Hopkins1*
Abstract 
Two different forms of clinical paratuberculosis in sheep are recognised, related to the level of bacterial coloniza-
tion. Paucibacillary lesions are largely composed of lymphocytes with few bacteria, and multibacillary pathology is 
characterized by heavily-infected macrophages. Analysis of cytokine transcripts has shown that inflammatory Th1/
Th17 T cells are associated with development of paucibacillary pathology and Th2 cytokines are correlated with 
multibacillary disease. The master regulator T cell transcription factors TBX21, GATA3, RORC2 and RORA are critical for 
the development of these T cell subsets. Sequence variations of the transcription factors have also been implicated in 
the distinct disease forms of human mycobacterial and gastrointestinal inflammatory diseases. Relative RT-qPCR was 
used to compare expression levels of each transcript variant of the master regulators in the ileo-caecal lymph nodes 
of uninfected controls and sheep with defined paucibacillary and multibacillary pathology. Low levels of GATA3 in 
multibacillary sheep failed to confirm that multibacillary paratuberculosis is caused simply by a Th2 immune response. 
However, high levels of TBX21, RORC2 and RORC2v1 highlights the role of Th1 and Th17 activation in paucibacillary 
disease. Increased RORAv1 levels in paucibacillary tissue suggests a role for RORα in Th17 development in sheep; 
while elevated levels of RORAv4 hints that this variant might inhibit RORα function and depress Th17 development in 
multibacillary sheep.
© 2016 The Author(s). This article is distributed under the terms of the Creative Commons Attribution 4.0 International License 
(http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, 
provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, 
and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/
publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Introduction
Paratuberculosis (Johne’s disease) is a common intestinal 
disease of ruminants caused by infection with the intra-
cellular bacterium Mycobacterium avium subspecies 
paratuberculosis (Map) [1]. As with tuberculosis [2], clin-
ical disease only develops in a minority of infected indi-
viduals, and in sheep the disease can be one of two forms. 
About 70% of the diseased animals develop multibacillary 
or lepromatous pathology with lesions in the terminal 
ileum composed of heavily infected macrophages [3, 4], 
and the remainder develop paucibacillary or tuberculoid 
pathology with characteristic lymphocytic infiltration, 
granulomatous inflammation and few bacteria.
The immunology of paratuberculosis in sheep is also 
similar to that of the tuberculoid and lepromatous forms 
of tuberculosis and leprosy [5, 6]. Multibacillary pathol-
ogy is linked with a strong Th2 response with high lev-
els of interleukin (IL)-5 [7, 8] and paucibacillary disease 
is associated with an inflammatory Th1/Th17 response, 
characterized by IL-12, IL-17A and IFNγ [7, 9, 10]. How-
ever, the immune response associated with the two forms 
of the disease is not a simple matter of Th1/Th2 discrimi-
nation as there seems to be a total T cell dysfunction and 
loss of homeostasis in animals with multibacillary pathol-
ogy [11–13], possibly concerned with changes to co-stim-
ulatory and second messenger expression [14, 15].
In common with tuberculosis and leprosy, the epide-
miology of paratuberculosis strongly suggests a genetic 
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susceptibility to disease severity and pathological form 
[16, 17]. Many of the genes associated with severity of 
human mycobacterial diseases and pathology belong to 
the pathways that control differential T cell activation 
[16]. The polarization of T cells into the various CD4+ T 
cell functional subsets occurs within organized lymphoid 
tissue and is largely controlled by the master regulator 
transcription factors that control differential cytokine 
production including Tbx21 or T-bet (TBX21), GATA-3 
(GATA3), RORγt (RORC2) and RORα (RORA); [18]. 
Tbx21 and GATA-3 are the regulators of Th1 and Th2 
differentiation respectively; initially by transactivation 
of relevant cytokine genes and also by reciprocal repres-
sion [19, 20]. RORγt is the major transcription factor that 
regulates Th17 development, and RORα is required for 
the maximum production of the cytokine IL-17A [21]. 
GATA-3 and RORα are also important in the develop-
ment and function of the different subsets of innate 
lymphoid cells 2 (ILC2), cells associated with mucosal 
surfaces in mice and important in the initiation of Th2 
responses [22].
Map is also implicated in the pathogenesis of Crohn’s 
disease [14], and these master regulators play important 
roles in the pathogenesis of this disease and other inflam-
matory diseases at mucosal sites. Tbx21 expression is 
implicated in the abnormal expression of IFNγ in Crohn’s 
disease and GATA-3 is involved in the immunopathology 
of ulcerative colitis [23, 24]. Th17 cells function largely in 
the development of inflammatory reactions and several 
inflammatory conditions are linked with ectopic Th17 
T cell activation; therefore RORγt and RORα are also 
implicated in inflammatory disease [25, 26]. Alterna-
tive splicing of exons (or part of an exon or intron) into a 
transcript introduces variations into many genes [27] and 
such variations in the transcripts of the human master 
regulator transcription factors can modify their functions 
[28–30].
We have recently identified two transcript variants of 
both sheep GATA3 and RORC2, a single TBX21 tran-
script and five variants of RORA [31]. In this study we 
compared the expression of each transcript variant of 
these four transcription factors, in the ileo-caecal lymph 
nodes (ICLN) that drain the disease lesions in the termi-
nal ileum adjacent to the ileo-caecal valve, in sheep with 
define multibacillary or paucibacillary pathology, to test 
the hypothesis that the pathological form of sheep para-
tuberculosis is associated with differential expression of 
individual T cell transcription factor variants.
Materials and methods
Animals, disease diagnosis and tissue collection
Animals with clinical disease were outbred female Black-
face or Blackface x sheep with naturally-acquired MAP 
infection (Table  1) from six farms; healthy, uninfected 
control sheep were all Blackface ewes from a single farm 
with no history of paratuberculosis. Paratuberculosis 
pathology in each animal was confirmed at post-mortem 
by haematoxylin and eosin and Ziehl-Neelsen histopa-
thology of the terminal ileum lesions and mesenteric 
lymph nodes [7]. PCR for insertion sequence 900 (IS900) 
was used to confirm infection. There were six animals 
in each of three groups; multibacillary (M), paucibacil-
lary (P) and uninfected controls (C). Tissue was ICLN 
removed at post-mortem, cut into blocks of  ~0.5  g and 
placed in five volumes of RNAlater (Ambion, UK), then 
incubated overnight at 4 °C and stored at −80 °C. No ani-
mals were euthanized specifically for this study; infected 
sheep were humanely culled for clinical reasons and 
uninfected controls were euthanized for reasons unre-
lated to this study (uninfected controls).
Is900 pcr
ICLN was tested for MAP infection by PCR for IS900. 
Two independent primer sets were used [32, 33]; set 
1 (for: GTTCGGGGCCGTCGCTTAGG; rev: GC 
GGGCGGCCAATCTCCTT) and set 2 (for: CTG 
GCTACCAAACTCCCGA; rev: GAACTCAGCGCCCA 
GGAT) generated products of 99 bp and 314 bp respec-
tively. Genomic DNA (gDNA) was purified using the 
Wizard® Genomic DNA Purification Kit (Promega, 
UK). All reactions used FastStart Taq DNA Polymerase 
(Roche Diagnostics, UK) following the manufacturer’s 
instructions, with 500  ng of gDNA and 0.2  μM of each 
primer. PCRs used a Veriti® Thermal Cycler (Applied 
Biosystems, UK) with four reactions performed for each 
primer set at four different annealing temperatures. PCR 
parameters were: 5 min at 95  °C, then 35 cycles of 15  s 
at 95  °C, 15  s at 55  °C, 58  °C, 60  °C, or 62  °C, and 30  s 
at 72  °C, with final elongation of 10  min at 72  °C. PCR 
products were separated by 2% agarose gel electrophore-
sis, purified with a MinElute Gel Extraction Kit (Qiagen, 
UK); cloned using a TOPO TA cloning kit (Invitrogen, 
UK) and sequenced using the BigDye Terminator v3.1 
Cycle Sequencing Kit and 3730 DNA Analyser (Applied 
Biosystems). The presence of an amplicon, confirmed by 
sequencing, from either primer set was taken as a posi-
tive indication for the presence of MAP; the absence of 
an amplicon in all PCR reactions was confirmation of 
absence of MAP infection.
Quantitative real‑time RT‑PCR analysis
Total RNA was obtained from  ~20  mg tissue using the 
Ribopure Kit (Ambion, UK) according to the manufac-
turer’s instructions, DNA was removed by On-column 
PureLink® DNase I treatment (Ambion). RNA quantity, 
quality and integrity were determined by NanoDrop 
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ND-1000 spectrophotometry and Agilent 2200 TapeSta-
tion system; all had an RNA Integrity Number of >7.4. 
cDNA was synthesised from 1  μg RNA using Super-
Script™ II RT with RNaseOUT (Invitrogen) and oligo-
dT(15) primer (Promega, UK), in a 20 μL final volume. 
Quantitative real-time RT-PCR (RT-qPCR) was per-
formed in 15  μL volumes containing 7.5 μL FastStart 
Universal SYBR Green Master (Rox) 2×  concentra-
tion (Roche), 2  μl template cDNA (diluted 1/10−1/40), 
1  μL dNTPs (10  mM) primers and nuclease-free water; 
primer sequences, Tm and product sizes (Additional 
file 1) have been published [31]. Reactions were prepared 
using a CAS-1200™ robot and performed on a Rotor-
Gene Q (Qiagen). All reactions had an efficiency >95% 
and R2 > 0.98; PCR amplicons were sequenced to confirm 
specificity. Three biological (RT) replicates per animal 
were assayed, each in duplicate and duplicate no-tem-
plate controls were included in all runs.
Relative gene expression levels were calculated in 
GenEx 5 (MultiD Analyses AB, Sweden) using the com-
parative 2−(ΔΔ Cq) method and normalized to the 
geometric mean of YWHAZ and SDHA. Fold changes 
were calculated from ΔCq values using GenEx. The dif-
ference between the group means for each gene was 
analysed using Graphpad Prism 6 by one-way ANOVA 
to determine overall significance, with Tukey’s multiple 
comparison test within ANOVA to determine signifi-
cance between groups.
Results
Paratuberculosis‑diseased and control sheep
The pathological characteristics of the three groups of 
animals is shown in Table  1. Representative haematox-
ylin and eosin and Ziehl-Neelsen histopathology of the 
lymph node is shown in Additional file  2. All infected 
animals were IS900 positive with both primer sets; all 
amplicons were sequenced and confirmed to be 100% 
identical with Mycobacterium avium subsp. paratuber-
culosis insertion sequence IS900 sequence (accession no. 
S74401.1). All uninfected control sheep were negative 
for IS900 PCR using both primer sets under all four PCR 
conditions.
Table 1 Details of paratuberculosis-diseased and control sheep
a  Source farms.
b  SGI (Severity of Granulomatous Inflammation) grading: based on total number of epithelioid macrophages and leukocyte distribution patterns of the terminal 
ileum [46].
c  AFB (Acid Fast Bacteria)—grading: grades 0–2 were defined as paucibacillary; grades 3–4 were defined as multibacillary observed in terminal ileum tissue.
d  IS900 PCR result using each of the two primer sets.
e  Diagnosis: based on histopathological observations.
Sheep ID Breed Origina Age (years) SGIb AFBc IS900d Diagnosise
SH.139 Blackface A 3 5 4 +, + M
SH.140 Blackface A 3 7 4 +, + M
SH.146 Blackface x B 2.5 5 4 +, + M
SH.190 Blackface C 3 5 4 +, + M
SH.199 Blackface C 2 6 4 +, + M
SH.204 Blackface D 1.5 6 4 +, + M
SH.107 Blackface x E 2.5 2.5 0 +, + P
SH.147 Blackface x B 2 3 0 +, + P
SH.155 Blackface F 3 2 0 +, + P
SH.160 Blackface x B 3 2.5 0 +, + P
SH.188 Blackface x B 4 4 1 +, + P
SH.205 Blackface D 4 2 0 +, + P
K207 Blackface G 2.5 0 0 −, − C
K208 Blackface G 2.5 0 0 −, − C
K213 Blackface G 2.5 0 0 −, − C
K224 Blackface G 2.5 0 0 −, − C
K227 Blackface G 2.5 0 0 −, − C
K229 Blackface G 2.5 0 0 −, − C
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Master regulator transcription variants
Cloning and sequencing of transcription factor tran-
scripts from abomasal lymph node identified two vari-
ants of GATA3, two variants of RORC2, five variants of 
RORA and a single TBX21 transcript [31]. In summary 
(Additional file  3), the two GATA3 variants include 
the full length GATA3 (LN848231) and GATA3v1 
(LN848232) that has a single codon deletion at the 5′ end 
of exon 3 (g.806_808delGAA) that encodes glutamic acid 
at position 260. The two RORC2 variants include a full 
length transcript (RORC2, LN848233) and a truncated 
transcript RORC2v1 (LN848234) with a 36  bp deletion 
(g.1237_1272del), which encodes GKYGGVELFRAL at 
position 359–370. The five RORA variants (LN848235–
LN848239) have different 5′ sequences, RORAv1, v2, v3 
and v5 have different translation start sites, and RORAv2 
and v4 have identical start sites. All five variants have the 
same ligand-binding domain but RORAv2 and v4 do not 
encode the DNA-binding domain. RORAv1, v3 and v5 
encode different NH2 sequences upstream of the DNA-
binding domain.
TBX21 and GATA3 expression
Relative RT-qPCR analysis of the master regulator tran-
scription factors that control Th1 and Th2 T cell dif-
ferentiation showed that there were overall significant 
differences in the expression of TBX21 (P  =  0.003) 
and GATA3 (P  =  0.046) but not the variant GATA3v1 
(P  =  0.32) (Table  2). Comparison between the groups 
(Figure 1) showed that TBX21 was significantly increased 
in paucibacillary sheep, resulting in a 2.6 fold change 
in the P vs. C comparison (P ≤  0.01) and a −1.88 fold 
change in the M vs. P comparison (p  ≤  0.05). Simi-
lar analysis for GATA3 showed a significant −2.08 fold 
change (P ≤ 0.05) in the M vs. P comparison, but no sig-
nificant differences were measured in the M vs. C (−1.6 
fold) and P vs. C (1.2 fold) comparisons. There were no 
significant differences between the groups with GATA3v1 
(Figure 1C). 
RORC2 expression
Quantification of two RORC2 variants showed overall 
significant differences (Table  2) for both the full length 
transcript (RORC2, P = 0.0004) and the truncated tran-
script (RORC2v1, P = 0.0026). Both transcripts behaved 
similarly in the between-group comparisons. RORC2 
and RORC2v1 (Figure 2) showed significant 2.4 and 3.09 
(both P ≤ 0.05) fold changes respectively in the M vs. C 
comparison; and significant 3.48 (P  ≤  0.001) and 3.49 
(P ≤ 0.01) fold changes respectively in the P vs. C com-
parison. Neither was significantly different in the M vs. P 
comparison.
RORA expression
Quantification of the RORA transcript variants could 
be performed only for RORAv1, RORAv4 and RORAv5 
because expression levels of RORAv2 and RORAv3 were 
too low for accurate measurements (detected at >30 
cycles, below the linear part of the titration curve). Over-
all significant differences (Table  2) were identified for 
both RORAv1 (P  =  0.0053) and RORAv4 (P  =  0.0002). 
RORAv5 was marginally insignificant (P  =  0.07). Com-
parison between the groups (Figure  3) showed that 
RORAv1 was significantly increased in lymph nodes from 
paucibacillary animals (P vs. C; 2.49 fold, P ≤  0.01 and 
(M vs. P; −1.9 fold, P ≤ 0.05). RORAv4 was significantly 
increased in both the M vs. C (2.78 fold, P ≤ 0.001) and P 
vs. C comparisons (2.89 fold, P ≤ 0.001), but was equally 
expressed in the multi- and paucibacillary groups (−1.04 
fold). RORVv5 was not significantly different in any of the 
three comparisons, although it was increased by 2.67 fold 
in the P vs. C comparison.
Table 2 Relative expression of transcription factors within the ICLN
a  Fold change (ΔΔCq values).
Italics: P ≤ 0.05.
Gene ANOVA P value Multi vs. control Pauci vs. control Multi vs. pauci
FCa P value FC P value FC P value
TBX21 0.003 1.38 ns 2.6 ≤0.01 −1.88 ≤0.05
GATA3 0.046 −1.6 ns 1.2 ns −2.08 ≤0.05
GATA3v1 0.32 −1.5 ns −1.25 ns −1.2 ns
RORC2 0.0004 2.4 ≤0.05 3.48 ≤0.001 −1.45 ns
RORC2v1 0.0026 3.09 ≤0.05 3.49 ≤0.01 −1.12 ns
RORAv1 0.0053 1.2 ns 2.49 ≤0.01 −1.9 ≤0.05
RORAv4 0.0002 2.78 ≤0.001 2.89 ≤0.001 −1.04 ns
RORAv5 0.07 1.8 ns 2.67 ns −1.47 ns
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Discussion
Previous studies investigating cytokine transcripts indi-
cated that sheep paucibacillary disease is strongly asso-
ciated with Th1/Th17 activation and that multibacillary 
pathology is linked to a Th2 T cell response [7, 34, 35]. 
Tbx21, GATA-3, RORγt and RORα are the master regu-
lator transcription factors responsible for controlling 
the polarization of these T cell subsets; and splice vari-
ants of these genes have been described in sheep, some 
of which are differentially expressed in gastrointestinal 
parasitic disease [31]. This study examined the relation-
ship between the expression of the different variants of 
these T cell master regulators and the two paratuberculo-
sis disease pathologies in naturally-infected sheep.
Only one TBX21 transcript has been described in 
sheep, which showed significant increased expression 
in ICLN from paucibacillary animals when compared to 
both uninfected controls (2.6 fold, P ≤ 0.01) and multi-
bacillary sheep (1.88 fold, P ≤ 0.05). These data contrast 
with measurements made from jejunal lymph nodes in 
experimentally-infected red deer [36], where there was 
no differential expression of TBX21, and IFNG levels 
were increased only in “severe disease” (multibacillary) 
cases. The difference might be associated with anatomical 
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Figure 1 Relative quantification of A TBX21, B GATA3 and C 
GATA3v1 in ICLN of paratuberculosis-diseased and uninfected 
control sheep. Each point is the mean ΔCq of three biological 
replicates per animal, each in duplicate. ANOVA: A TBX21, P = 0.003; 
B GATA3, P = 0.046; C GATA3v1, P = 0.32; error bars, ± SD. *≤ 0.05, 
>0.01; **≤0.01, 0.001; ***≤0.001.
A  RORC
Control Multi Pauci
Control Multi Pauci
4
5
6
7
8
B  RORCv1
4
5
6
7
8
**
*
***
*
R
el
at
iv
e 
E
xp
re
ss
io
n 
∆C
q
Figure 2 Relative quantification of A RORC2 and B RORC2v1 
in ICLN of paratuberculosis-diseased and uninfected control 
sheep. Each point is the mean ΔCq of three biological replicates per 
animal, each in duplicate. ANOVA: A RORC2, P = 0.0004; B RORC2v1, 
P = 0.0026; error bars, ± SD. *≤0.05, >0.01; **≤0.01, 0.001; ***≤0.001.
Page 6 of 8Nicol et al. Vet Res  (2016) 47:83 
location of the lymph nodes, as Begg et al. [37] showed 
that responses to infection varied with their position. 
The immune response to paratuberculosis is greatest at 
the location of the most severe lesions [37]; the terminal 
ileum is a major site of the paratuberculosis lesions in 
sheep [3] and the ICLN is the major immune inductive 
site for that tissue. Tbx21 is required for Th1 activation 
as it induces the expression of IFNγ [18]; which is the 
critical cytokine for controlling intracellular mycobacte-
rial replication [6]. High levels of both TBX21 and IFNG 
transcripts are seen in human Crohn’s disease [38] and 
TBX21 SNPs are linked with resistance to human pulmo-
nary tuberculosis [39]. In sheep paratuberculosis there-
fore, high levels of TBX21 expression may explain the 
increased levels of IFNγ [7, 40] and the consequent low 
numbers of MAP in paucibacillary lesions.
The expression of the full length GATA3 variant was 
significantly increased (2.08 fold, P ≤ 0.05) in the pauci-
bacillary sheep in comparison to multibacillary animals 
but was not significantly different in either of the diseased 
vs. control comparisons. GATA-3 is required for Th2 dif-
ferentiation as it transactivates the IL4 cassette and pro-
motes the transcription of IL4, IL5 and IL13 [41]; it also 
inhibits Th1 responses and is repressed during Th1 devel-
opment [42]. The increased levels of GATA3 transcripts 
in paucibacillary sheep, with (non-significantly) reduced 
levels in multibacillary sheep (−1.6 fold) is similar to that 
found in red deer with high levels of GATA3 (and IL4) in 
“minimal disease” (paucibacillary) and reduced expres-
sion in “severe disease” [36]; and these authors suggested 
that Th2 responses act to control immunopathology in 
infected animals, and that loss of these responses leads 
to the multibacillary disease state. GATA3v1 expression 
showed no significant changes in any of the three com-
parisons. This variant, which is also found in humans, 
encodes for GATA-3 with a deletion at position 260 (glu-
tamic acid). The deletion is not within the transactiva-
tion domains or either of the zinc-finger domains, nor is 
it associated with the conserved YxKxHxxxRP motif at 
position 345–354 that seems to control Th2 cytokine pro-
duction [43]. To date this is the only study that describes 
any biological difference between full length GATA3 and 
GATA3v1 in any species.
Full length RORC2 expression was significantly 
increased in both the P vs. C (3.48 fold, P ≤ 0.001) and M 
vs. C (2.4 fold, P ≤ 0.05) comparisons. RORC2v1 behaved 
in an almost identical manner. Increased RORγt expres-
sion in humans is associated with a range of inflamma-
tory pathologies, including inflammatory bowel disease 
[44]; and these data imply that RORγt-mediated Th17 
activity is an important aspect of the chronic inflam-
mation seen in both pathological forms of paratubercu-
losis. However, the 1.45 fold increase of RORC2 in the 
P vs. M comparison (whilst not significant) indicates a 
trend of increased Th17 cell function in the paucibacil-
lary immunopathology in comparison to multibacillary 
disease. The twelve amino acid deletion encoded by the 
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Figure 3 Relative quantification of A RORAv1, B RORAv4 and C 
RORAv5 in ICLN of paratuberculosis-diseased and uninfected 
control sheep. Each point is the mean ΔCq of three biological rep-
licates per animal, each in duplicate. ANOVA: A RORAv1, P = 0.0053; 
B RORAv4, P = 0.0002; C RORAv5, P = 0.07; error bars, ± SD. *≤0.05, 
>0.01; **≤0.01, 0.001; ***≤0.001.
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RORC2v1 variant is within the predicted ligand-binding 
domain [45], which implies a modification in function; a 
similar RORC2 variant in humans suppresses IL17A and 
IL21 transcription and consequently inhibits Th17 func-
tion [29]. However, there is no indication in these studies 
that the two sheep variants have any different functions.
Only three of the five RORA variants showed meas-
urable levels of expression. RORAv1 was significantly 
increased in paucibacillary sheep in comparison to both 
control (2.49 fold, P ≤ 0.01) and multibacillary sheep (1.9 
fold, P ≤ 0.05); and RORAv4 was increased in both the M 
vs. C (2.78 fold, P ≤ 0.001) and P vs. C comparisons (2.89 
fold, P ≤ 0.001). RORAv5 showed no significant differen-
tial expression but was 2.67 fold increased in the P vs. C 
comparison (but not significant). The biological activi-
ties of RORα are mediated by both the ligand-binding 
and DNA-binding domains [30]. In addition, the amino 
terminal A and B domains play important roles in intra-
cellular localization, binding specificity and cell tropism. 
RORAv1 and RORAv5 possesses both ligand- and DNA- 
binding domains but different A and B domains [31]; 
RORAv4, which encodes the same protein as RORAv2, 
possesses the conserved ligand-binding domain but lacks 
the A, B and DNA-binding domains.
Optimal Th17 differentiation requires the co-expres-
sion of both RORγt and RORα [21] and the significantly 
high levels of RORAv1 in paucibacillary (in comparison 
to both multibacillary and control sheep) further empha-
sises an important role for Th17 activation in paucibacil-
lary (tuberculoid) pathology. It is possible that RORAv4, 
which is found in high levels in both paucibacillary and 
multibacillary sheep, could compete with RORAv1 for 
ligand binding and inhibit its function, most effectively 
in those animals with lower levels of RORAv1 (i.e. multi-
bacillary), with consequent reduction in Th17 activation. 
This is similar to the differential expression patterns of 
RORAv2 and RORAv5 seen in parasitic disease patholo-
gies [31].
In conclusion, this study measures the expression of 
the transcript variants of the master regulator transcrip-
tion factors that control Th1, Th2 and Th17 T cell dif-
ferentiation, in sheep with defined paucibacillary and 
multibacillary paratuberculosis pathology. Relatively low 
levels of GATA3 in multibacillary animals confirms the 
data from red deer, but does not confirm that multibacil-
lary (lepromatous) paratuberculosis is primarily caused 
by Th2 activation. High levels of expression of TBX21, 
RORC2 and RORC2v1 highlights the role of both Th1 
and Th17 in controlling bacterial replication in pauci-
bacillary disease, and increased expression of RORAv1 
emphasises that RORα plays an important part in Th17 
development in this disease. The differentiation between 
paucibacillary and multibacillary pathology might also 
concern RORAv4, which may inhibit Th17 activation in 
multibacillary disease and further contribute to T cell 
dysfunction.
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